Dropper Plus Point-of-Care Urinalysis Dipstick Control kit The Quantimetrix Dropper Plus Point-of-Care Urinalysis Dipstick Control is intended as a control for urinalysis reagent strips, microalbumin, and creatinine by the listed test methods, and as a control for confirmatory tests such as K-CHECK and Ictotest reagent tablets, and for hCG methods.

Recall Insight

This FDA Devices action (record #Z-2257-2018) was formally reported on June 27, 2018, with the manufacturer initiating the action on December 21, 2017. It is classified under Low severity (Class III), with a current status of Terminated. Quantimetrix Corporation is listed as the recalling firm, operating out of Redondo Beach, CA. Federal records indicate 20 kits units are affected.

The documented reason for this recall is: The kits contained an incorrect lot of Dropper Plus Level 1 vials Distribution data in the federal record shows the product reached: US Distribution to the state of : Kansas. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 8 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.